Abstract

The dopamine transporter shapes dopaminergic neurotransmission by clearing extracellular dopamine and by replenishing vesicular stores. The dopamine transporter carries an endogenous binding site for Zn(2+), but the nature of the Zn(2+)-dependent modulation has remained elusive: both, inhibition and stimulation of DAT have been reported. Here, we exploited the high time resolution of patch-clamp recordings to examine the effects of Zn(2+) on the transport cycle of DAT: we recorded peak currents associated with substrate translocation and steady-state currents reflecting the forward transport mode of DAT. Zn(2+) depressed the peak current but enhanced the steady-state current through DAT. The parsimonious explanation is preferential binding of Zn(2+) to the outward facing conformation of DAT, which allows for an allosteric activation of DAT, in both, the forward transport mode and substrate exchange mode. We directly confirmed that Zn(2+) dissociated more rapidly from the inward- than from the outward-facing state of DAT. Finally, we formulated a kinetic model for the action of Zn(2+) on DAT that emulated all current experimental observations and accounted for all previous (in part contradictory) findings. Importantly, the model predicts that the intracellular Na(+) concentration determines whether substrate uptake by DAT is stimulated or inhibited by Zn(2+). This prediction was directly verified. The mechanistic framework provided by the current model is of relevance for the rational design of allosteric activators of DAT. These are of interest for treating de novo loss-of-function mutations of DAT associated with neuropsychiatric disorders such as attention deficit hyperactivity disorder (ADHD).

Highlights

  • Zn2ϩ was originally proposed to inhibit dopamine uptake by the dopamine transporter (DAT)

  • These are of interest for treating de novo loss-of-function mutations of DAT associated with neuropsychiatric disorders such as attention deficit hyperactivity disorder (ADHD)

  • We show that the kinetics of the transport cycle dictate an intricate coupling between the allosteric effect of Zn2ϩ and the intracellular Naϩ concentration: at low [Naϩ]i binding of Zn2ϩ affords accelerated cycling, but at high [Naϩ]i it acts as a brake

Read more

Summary

Background

Zn2ϩ was originally proposed to inhibit dopamine uptake by the dopamine transporter (DAT). The model predicts that the intracellular Na؉ concentration determines whether substrate uptake by DAT is stimulated or inhibited by Zn2؉. The transport cycle of DAT is consistent with the alternating access model [1]: the transporter presents a substrate-binding site to the extracellular side of the membrane; upon binding of substrate and co-substrates (Naϩ and ClϪ), conformational changes occlude the extracellular access pathway and expose the solutes to the intracellular space This results in their transport into the cell. We show that the kinetics of the transport cycle dictate an intricate coupling between the allosteric effect of Zn2ϩ and the intracellular Naϩ concentration: at low [Naϩ]i binding of Zn2ϩ affords accelerated cycling, but at high [Naϩ]i it acts as a brake

Experimental Procedures
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call